Literature DB >> 7686111

What are the types and cellular sources of free radicals in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus?

T Mandrup-Poulsen, J A Corbett, M L McDaniel, J Nerup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7686111     DOI： 10.1007/bf00402286

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  19 in total

1.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

2.  Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation.

Authors:  K D Kröncke; V Kolb-Bachofen; B Berschick; V Burkart; H Kolb
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

3.  Islet cytotoxicity of interleukin 1. Influence of culture conditions and islet donor characteristics.

Authors:  T Mandrup-Poulsen; G A Spinas; S J Prowse; B S Hansen; D W Jørgensen; K Bendtzen; J H Nielsen; J Nerup
Journal:  Diabetes       Date:  1987-05       Impact factor: 9.461

4.  Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.

Authors:  J A Corbett; J L Wang; M A Sweetland; J R Lancaster; M L McDaniel
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

5.  Interleukin-1 beta induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages.

Authors:  D L Eizirik; E Cagliero; A Björklund; N Welsh
Journal:  FEBS Lett       Date:  1992-08-24       Impact factor: 4.124

6.  Heat shock protein induction in rat pancreatic islets by recombinant human interleukin 1 beta.

Authors:  S Helqvist; B S Polla; J Johannesen; J Nerup
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

7.  Interleukin-1 beta increases the activity of superoxide dismutase in rat pancreatic islets.

Authors:  L A Borg; E Cagliero; S Sandler; N Welsh; D L Eizirik
Journal:  Endocrinology       Date:  1992-05       Impact factor: 4.736

8.  Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.

Authors:  J A Corbett; R G Tilton; K Chang; K S Hasan; Y Ido; J L Wang; M A Sweetland; J R Lancaster; J R Williamson; M L McDaniel
Journal:  Diabetes       Date:  1992-04       Impact factor: 9.461

Review 9.  Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM.

Authors:  J A Corbett; M L McDaniel
Journal:  Diabetes       Date:  1992-08       Impact factor: 9.461

10.  Oxygen free radical scavengers protect rat islet cells from damage by cytokines.

Authors:  W Sumoski; H Baquerizo; A Rabinovitch
Journal:  Diabetologia       Date:  1989-11       Impact factor: 10.122
View more
  4 in total

Review 1.  The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells.

Authors:  D L Eizirik; M Flodström; A E Karlsen; N Welsh
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

Review 2.  On the pathogenesis of IDDM.

Authors:  J Nerup; T Mandrup-Poulsen; S Helqvist; H U Andersen; F Pociot; J I Reimers; B G Cuartero; A E Karlsen; U Bjerre; T Lorenzen
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

3.  Administration of a nitric oxide synthase inhibitor does not suppress low-dose streptozotocin-induced diabetes in mice.

Authors:  G Papaccio; V Esposito; M V Latronico; F A Pisanti
Journal:  Int J Pancreatol       Date:  1995-02

4.  Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4.

Authors:  H Rothe; A Faust; U Schade; R Kleemann; G Bosse; T Hibino; S Martin; H Kolb
Journal:  Diabetologia       Date:  1994-11       Impact factor: 10.122
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.